MPO and colorectal carcinoma: It lowers lipid peroxidation, IL-1β, inducible nitric oxide synthase (iNOS), myeloperoxidase (MPO), and nitric oxide (NO) levels, suppressing neutrophil infiltration and ROS-related damage, highlighting its potential as a dietary therapeutic agent for inflammation-associated CRC prevention [78].